GluK1 antagonists from 6-(carboxy)phenyl decahydroisoquinoline derivatives. SAR and evaluation of a prodrug strategy for oral efficacy in pain models

  1. Martinez-Perez, J.A.
  2. Iyengar, S.
  3. Shannon, H.E.
  4. Bleakman, D.
  5. Alt, A.
  6. Arnold, B.M.
  7. Bell, M.G.
  8. Bleisch, T.J.
  9. Castaño, A.M.
  10. Del Prado, M.
  11. Dominguez, E.
  12. Escribano, A.M.
  13. Filla, S.A.
  14. Ho, K.H.
  15. Hudziak, K.J.
  16. Jones, C.K.
  17. Mateo, A.
  18. Mathes, B.M.
  19. Mattiuz, E.L.
  20. Ogden, A.M.L.
  21. Simmons, R.M.A.
  22. Stack, D.R.
  23. Stratford, R.E.
  24. Winter, M.A.
  25. Wu, Z.
  26. Ornstein, P.L.
  27. Erakutsi egile guztiak +
Aldizkaria:
Bioorganic and Medicinal Chemistry Letters

ISSN: 0960-894X 1464-3405

Argitalpen urtea: 2013

Alea: 23

Zenbakia: 23

Orrialdeak: 6459-6462

Mota: Artikulua

DOI: 10.1016/J.BMCL.2013.09.046 GOOGLE SCHOLAR